Allarity Therapeutics Inc Total Liabilities

Latest as of December 2025: $8.43 Million USD

Allarity Therapeutics Inc total liabilities. Based on the latest financial reports, Allarity Therapeutics Inc (ALLR) has total liabilities worth $8.43 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ALLR cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Allarity Therapeutics Inc (2013–2025)

Total liabilities of Allarity Therapeutics Inc from 2013 to 2025. This chart illustrates how Allarity Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Allarity Therapeutics Inc to see how much of total assets are deployed in long-term investments.

Allarity Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Allarity Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
RPCG Public Company Limited BK:RPC	Thailand	฿5.06 Billion
Scidev Ltd AU:SDV	Australia	AU$18.84 Million
Bright Scholar Education Holdings Ltd Class A NYSE:BEDU	USA	$238.96 Million
Rocketdna Ltd AU:RKT	Australia	AU$3.79 Million
Southern Fertilizer JSC VN:SFG	Vietnam	₫1.31 Trillion
Hands Corporation Ltd KO:143210	Korea	₩607.93 Billion
Chiangmai Frozen Foods Public Company Limited BK:CM	Thailand	฿125.77 Million
Kyntra Bio, Inc. NASDAQ:KYNB	USA	$109.22 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Allarity Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Allarity Therapeutics Inc.

Liquidity & Leverage Metrics

Allarity Therapeutics Inc Total Liabilities Ratios Explained

Allarity Therapeutics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.13	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Allarity Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Allarity Therapeutics Inc (2013–2025)

The table below shows the annual total liabilities of Allarity Therapeutics Inc from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	$8.43 Million	-22.23%
2024-12-31	$10.84 Million	-25.83%
2023-12-31	$14.61 Million	+15.48%
2022-12-31	$12.65 Million	-58.98%
2021-12-31	$30.85 Million	+370.83%
2020-12-31	$6.55 Million	-38.79%
2019-12-31	$10.70 Million	+0.17%
2018-12-31	$10.69 Million	+529.09%
2017-12-31	$1.70 Million	+27.11%
2016-12-31	$1.34 Million	+157.91%
2015-12-31	$518.15K	+3489.03%
2014-12-31	$14.44K	+15.01%
2013-12-31	$12.55K	--

About Allarity Therapeutics Inc

NASDAQ:ALLR USA Biotechnology

Market Cap

$17.47 Million

Market Cap Rank

#25375 Global

#5379 in USA

Share Price

$1.13

Change (1 day)

+15.58%

52-Week Range

$0.81 - $1.77

All Time High

$1000000.00